Efficacy Of The Tyrosine Kinase Inhibitor Lapatinib In The Treatment Of Patients With Her2-Negative Metastatic Breast Cancer And Her2-Positive Circulating Tumor Cells - Results From The Randomized Phase Iii Detect Iii Trial

CANCER RESEARCH(2021)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要